Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy - A randomized controled trial

Journal article

Peer reviewed

S. C. Apfel, S. Schwartz, B. T. Adornato, R. Freeman, V. Biton, Marc S. Rendell, A. Vinik, M. Giuliani, J. C. Stevens, R. Barbano, …

JAMA, Vol.284(17), pp.2215-2221

11/01/2000

Metrics

6 Record Views

Title: Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy - A randomized controled trial
Creators: S. C. Apfel (Author)
S. Schwartz (Author)
B. T. Adornato (Author)
R. Freeman (Author)
V. Biton (Author)
Marc S. Rendell (Author) - Creighton University
A. Vinik (Author)
M. Giuliani (Author)
J. C. Stevens (Author)
R. Barbano (Author)
P. J. Dyck (Author)
Publication Details: JAMA, Vol.284(17), pp.2215-2221
Number of pages: 2215-2221
Identifiers: 991005932390602656
Academic Unit: School of Medicine; Endocrine
Resource Type: Journal article